DTC
IMA

Deep Track Capital’s ImageneBio Inc IMA Stock Holding History

Deep Track Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-878,516
Closed -$7.16M – 66
2025
Q3 		$7.16M Buy
878,516
+668,890
+319% +$8.87M 0.2% 43
2025
Q2 		$3.37M Hold
209,626
– – 0.11% 58
2025
Q1 		$3.22M Buy
+209,626
New +$3.62M 0.1% 65

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Deep Track Capital's IMA Position: Q4 2025 in Review

Deep Track Capital sold out of ImageneBio Inc (IMA) in Q4 2025, closing a stake of 878,516 shares — an estimated $7.16M sold.

Deep Track Capital first reported a position in IMA in Q1 2025 and held it in 3 quarters. The position peaked at $7.16M in Q3 2025. 41 funds tracked by Wall St. Rank hold IMA as of Q4 2025.

  • Deep Track Capital reported no remaining ImageneBio Inc position as of Q4 2025 after selling out during the quarter.
  • Deep Track Capital sold 878,516 ImageneBio Inc shares in Q4 2025, an estimated $7.16M.
  • Deep Track Capital first reported a position in ImageneBio Inc in Q1 2025 and held it in 3 quarters.
  • Deep Track Capital's ImageneBio Inc position peaked at $7.16M in Q3 2025.
  • 41 funds tracked by Wall St. Rank held ImageneBio Inc as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.